Hengrui Medicine (600276.SH) expects that its H shares will be listed on the Hong Kong Stock Exchange on May 23rd.

Zhitong Finance APP News, Hengrui Medicine (600276.SH) announced that the preliminary price range for the company's H-share issue is determined to be between 41.45 Hong Kong dollars and 44.05 Hong Kong dollars. The company's H shares will be publicly offered in Hong Kong starting on May 15, 2025, with an expected end date of May 20, 2025. The issuing price is expected to be announced by May 22, 2025 (including that day).